NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 10, 2023 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU) , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, announces that it has filed…


Previous articlePsychedelics Weekly – Drug-Free Digital Trips, The Prevalence of Challenging Experiences, and the End of Synthesis Institute
Next articleReunion Neuroscience Files Lawsuit Against Mindset Pharma